We have found a novel isoform of the mouse type 2 Ins(1,4,5)P $ receptor [Ins(1,4,5)P $ R] mRNA by reverse transcriptasemediated PCR analysis. The novel isoform, which was expressed specifically in skeletal muscle and heart, was generated by the inclusion of a novel exon. As this exon contains a stop codon, the isoform encodes a putative protein (designated TIPR) consisting of 175 acid residues of the type 2 Ins(1,4,5)P $ R and the following six residues derived from this exon. We transfected the cDNA of
INTRODUCTION

Ins(1,4,5)P
$ is a second messenger in the intracellular signal transduction system [1] . Its target, Ins(1,4,5)P $ receptor [Ins(1,4,5)P $ R], is a channel for Ins(1,4,5)P $ -induced release of Ca# + from intracellular stores [2, 3] . The increase in Ca# + in cytoplasm mediated by Ins(1,4,5)P $ R is important for various cellular processes such as neurotransmission, plasticity of synaptic response and smooth-muscle contraction [4] .
Ins(1,4,5)P $ R is composed of approx. 2700 residues. One Ins(1,4,5)P $ molecule binds to one Ins(1,4,5)P $ R molecule ; four Ins(1,4,5)P $ R molecules compose a functional channel [5] [6] [7] [8] . The primary structure is divided into three domains : the N-terminal domain, the C-terminal transmembrane domain and the regulatory domain [2] . The C-terminal domain has six transmembrane regions and is considered to form the Ca# + channel structure [9] . The N-terminal domain is considered to be responsible for ligand binding [5, 6] . Interestingly, Joseph et al. [10] suggest that the Nterminal domain interacts with the C-terminal domain ; they think that the N-terminal domain regulates the channel activity of the receptor. The regulatory domain is located between the Nand C-terminal domains and contains the sites for modulators of Ins(1,4,5)P $ R, such as protein kinase A, ATP and Ca# + , which are thought to regulate the channel activity of Ins(1,4,5)P $ R [3] . Three subtypes of Ins(1,4,5)P $ R are known to be encoded by different genes (types I, II and III) [3, 11] . These subtypes show approx. 60 % identity of their amino acid sequences. Further subtypes are produced by alternative splicing of mRNA [5, [12] [13] [14] [15] [16] [17] . Because they show different patterns of expression in different tissues, each subtype might have a specific role. In the present study we found a novel alternatively spliced product of mouse type 2 Ins(1,4,5)P $ R [Ins(1,4,5)P $ R2] mRNA. We show that this mRNA isoform is produced exclusively in skeletal muscle and Abbreviations used : Ins(1,4,5)P 3 R, Ins(1,4,5)P 3 receptor ; Ins(1,4,5)P 3 R2, type 2 Ins(1,4,5)P 3 R ; TIPR, truncated protein of Ins(1,4,5)P 3 receptor. 1 To whom correspondence should be addressed (e-mail gorou.kuwajima!shionogi.co.jp). The nucleotide sequence data reported will appear in DDBJ, EMBL and GenBank Nucleotide Sequence Databases under the accession numbers AB012393 and AB012610.
this isoform into COS-7 cells ; these cells expressed a 24 kDa protein that was recognized by an antibody against TIPR produced in Escherichia coli. The isoform encoding TIPR was also found in human skeletal muscle and heart. The N-terminal region of Ins(1,4,5)P $ R is suggested to have a role in ligand binding and to interact with the C-terminal channel domain of Ins(1,4,5)P $ R itself. TIPR might regulate the Ins(1,4,5)P $ signal pathway in both muscles.
heart, and encodes a putative protein consisting mainly of the Nterminal 175 residues of Ins(1,4,5)P $ R2. We designate this protein TIPR, from ' truncated protein of Ins(1,4,5)P $ receptor '.
EXPERIMENTAL RNA preparation, cDNA synthesis and reverse transcriptasemediated PCR (RT-PCR)
All animals were treated ethically in accordance with the rules of the Shionogi Animal Use and Care Committee. ICR mice were anaesthetized and killed by decapitation, and tissues were dissected. The total RNA was isolated by the single-step acid guanidinium thiocyanate phenol\chloroform extraction method [18] . Poly(A) + RNA was purified from total RNA with OligotexdT30 (Takara Shuzo). Poly(A) + RNA from human skeletal muscle and heart was purchased from Clontech. Oligo(dT "& )-primed synthesis of the cDNA first strand was performed with Moloney murine leukaemia virus reverse transcriptase. PCR primers for the amplification of mouse Ins(1,4,5)P $ R2 cDNA are listed as follows : P1, 5h-TCACCCTTGCGAGCAGCGGA-3h [corresponds to sense sequence from nt k54 to k35 of rat Ins(1,4,5)P $ R2 cDNA, numbered from the initiation codon] ; P2, 5h-ACGACTTTATCTCCCACGAC-3h (anti-sense sequence from nt 529-548) ; P3, 5h-TACGCGGAGGGCTCGGTCAAT3h (sense sequence from nt 52-71) ; P4, 5h-GCTCCTGGTTC-TACATCCAT-3h (sense sequence from nt 473-492) ; P5, 5h-AACAGGCTGTTCCACTGTCC-3h (anti-sense sequence from nt 889-908). These primers were derived from the sequence of rat Ins(1,4,5)P $ R2 cDNA (P1, P2, P3 and P5) or from the sequence of the mouse counterpart clarified in this study (P4). The primers PH1 and PH2 were derived from human Ins(1,4,5)P $ R2 cDNA sequence (DDBJ accession no. D26350) : PH1, 5h-ATGCGTG-TGTCCTTGGATGC-3h [sense sequence from nt 439-458 of human Ins(1,4,5)P $ R2 cDNA, numbered from the initiation codon] ; and PH2, 5h-GTAGCAGAAGTAGCTGATTG-3h (anti-sense sequence from nt 808-827). For amplification of the Ins(1,4,5)P $ R2 cDNA fragments, 30-40 cycles of PCR reaction consisting of the following steps were performed : denaturation at 94 mC for 1 min, annealing at 50-55 mC for 2 min, and elongation by AmpliTaq DNA polymerase at 74 mC for 3 min. The PCR products were subcloned into TA plasmids (Invitrogen) and subjected to DNA sequence analysis.
PCR analysis of genome structure
ICR mouse liver was homogenized with a Teflon Potter homogenizer in a solution containing 10 mM Tris\HCl and 100 mM EDTA, pH 8.0, and incubated at 37 mC for 1 h in the same solution supplemented with 0.5 % sarcosyl and 50 µg\ml RNase A. The mixture was treated overnight with 100 µg\ml proteinase K at 60 mC. Genomic DNA in the mixture was extracted with phenol, phenol\chloroform and diethyl ether. For PCR amplification of mouse genomic DNA fragments that span the sequence of 57 bp (S57) between nt 525 and 526 of Ins(1,4,5)P $ R2 cDNA (also see the Results and Discussion section), the following primers were used : P6, 5h-CTGAGAA-GCGAGGGTGATAA-3h [corresponds to the sense sequence from nt 505-524 of mouse Ins(1,4,5)P $ R2 cDNA] and P7, 5h-TTACAGGCATCAGAACGACT-3h [the anti-sense sequence from nt 543-582 of mouse Ins(1,4,5)P $ R2 cDNA]. The PCR products were subcloned into TA plasmids (Invitrogen) and their sequences were determined on both strands.
Preparation of an antibody against TIPR
Recombinant TIPR was expressed in Escherichia coli under the control of the lacZ promoter, as follows. The 589 bp fragment from nt 2-590 of mouse Ins(1,4,5)P $ R2 cDNA that includes S57 was amplified by PCR with the following anchor primers : HindIII site-including sense primer, 5h-GCAGAAGCTTGTCTGACA-AAATGT-3h ; BamHI site-including anti-sense primer, 5h-GACTGGATCCCCCACGACGATCTA-3h. The PCR product was digested with HindIII and BamHI, then ligated to the E. coli vector pUC119 digested with the HindIII and BamHI. The E. coli strain XL1 blue transformed with the resultant plasmid was grown in Luria-Bertani medium under the control of isopropyl β--thiogalactoside. The harvested cells were sonicated and inclusion bodies were prepared by the method of Marston et al. [19] . TIPR contained in the inclusion bodies was dissolved with 4 M urea and further purified by FPLC on a Mono-S HR 5A (Pharmacia) column ; in the resultant solution, any protein other than the recombinant TIPR was not detected by SDS\PAGE followed by staining with silver. Purified TIPR was suspended with Freund's incomplete adjuvant (Difco) and injected into a rabbit (Japanese White ; KBL Japan). Immunoglobulins prepared from the antiserum by precipitation with 33 %-satd. (NH % ) # SO % were dissolved in 10 mM phosphate\150 mM NaCl (pH 7.2) and were used as an anti-TIPR antibody.
TIPR expression in COS-7 cells
A PCR product amplified from the S57-including form of mouse Ins(1,4,5)P $ R2 cDNA with primers P1 and P2, which contained the TIPR-encoding region, was subcloned into plasmid pCRII. A 700 bp fragment of EcoRI digests of the resultant plasmid DNA was inserted at the EcoRI site of the mammalian expression vector pMIKneo (a gift from Dr. Kazuo Maruyama), which has the 16 S intron of SV40, the multi-cloning site of pBluescript (Stratagene) and the poly(A) + signal of SV40 at the downstream region of the SRα promoter (K. Maruyama, personal communication) ; the inserted cDNA would be expressed under the control of SRα promoter [20] . The resultant plasmid was transfected into COS-7 cells with Lipofectamine (Gibco BRL). At 2 days after transfection, cells were harvested, homogenized with a Teflon Potter homogenizer and subjected to SDS\PAGE [15 % (w\v) gel] [21] . After electrophoresis, proteins were transferred to a PVDF membrane (Millipore). The membrane was soaked in 0.5 % skimmed milk in 10 mM phosphate\150 mM NaCl (pH 7.2), incubated with anti-TIPR antibody and then with horseradish peroxidase-conjugated goat immunoglobulin against rabbit IgG. Peroxidase-coupled detection of signals was performed with an enhanced chemiluminescence kit (Amersham).
RESULTS AND DISCUSSION
To amplify the 5h-terminal regions of mouse Ins(1,4,5)P $ R2 cDNA, we designed three pairs of PCR primers, P1 and P2, P3 and P2, and P4 and P5, from the cDNA sequence of rat Ins(1,4,5)P $ R2 ; these sets of primers would span nt k54 to 548, nt 52-548 and nt 473-908 respectively (numbered from the initiation codon) [22] . By RT-PCR for various mouse tissues with these primer sets, we obtained fragments of the expected sizes ( Figure 1 ). DNA sequences and the encoded amino acid sequences showed that the amplified fragments corresponded to the expected region of rat Ins(1,4,5)P $ R2 cDNA (Figure 2A ). Furthermore in each primer set of PCR a larger fragment was also amplified from skeletal muscle and heart (Figure 1 ). DNA
Figure 1 RT-PCR analysis of splicing patterns at S57
Gel electrophoresis of PCR products with 2 % agarose. sequence analysis showed that each of the larger fragments corresponded to the expected region of mouse Ins(1,4,5)P $ R2 cDNA and, in addition, included S57 (Figure 2A) . Interestingly, the sequence of S57 had not yet been reported. It has five stop codons in the same frame with that of Ins(1,4,5)P $ R2. Therefore the S57-including cDNA encodes the sequence of 181 residues consisting of the N-terminal 175 residues of Ins(1,4,5)P $ R2 and the following six residues derived from S57 (Figures 2A and 2B) . We designated the protein of this sequence TIPR. The PCR product containing S57 was amplified only from skeletal muscle and heart (Figure 1 ). This result shows that TIPR is expressed
Figure 3 Arrangement of exons and introns around S57
Exons are indicated by boxes. Nucleotides at the splice sites fitting the GT/AT rule are underlined.
Figure 4 Immunoblot analysis of TIPR expressed in COS-7
Homogenate (4 µg) of COS-7 cells that had pMIKneo containing TIPR (TIPR-transfected) or pMIKneo (control) was subjected to immunoblot analysis with anti-TIPR antibody. The position of TIPR is indicated by an arrowhead. The positions of molecular mass markers are indicated (in kDa) at the right.
specifically in these tissues. Furthermore the PCR product including S57 was present in a lower level than that excluding S57 in skeletal muscle, whereas both PCR products were present at similar levels in heart. Although we did not ensure that the results of PCR in this study were quantitative, these results suggested that the expression level of TIPR was similar to that of Ins(1,4,5)P $ R2 in heart but lower than that of Ins(1,4,5)P $ R2 in skeletal muscle.
We examined the genomic structure around S57. PCR with a primer set P6 and P7, which was designed from the mouse cDNA sequence to span S57, generated a single product of 4.3 kbp from the mouse genomic DNA. Comparison of the sequence of this product with the cDNA sequence revealed the exon\intron organization around S57 (Figure 3) . S57 corresponded to an exon of 57 bp flanked by introns of 1.3 kbp and 2.9 kbp. The sequences of the 5h and 3h termini of both introns were in accordance with the GT\AG rule [23] . These results show that the inclusion or exclusion of S57 in Ins(1,4,5)P $ R2 mRNA are mediated by alternative splicing.
We examined whether TIPR was really translated from a novel mRNA isoform that contained S57. We transfected the mouse cDNA fragment encoding TIPR into COS-7 cells under the control of SRα promoter. A band of 24 kDa was detected in the cells carrying the cDNA in an immunoblot analysis with the anti-TIPR antibody (Figure 4 ). This band was not detected in the cells that did not have the cDNA. Furthermore when the antibody was premixed with the recombinant TIPR, only the band of 24 kDa disappeared. These results show that TIPR can be
Figure 5 Nucleotide sequence around human S57
The encoded amino acid sequence, the C-terminus of TIPR, is presented below. The corresponding sequence of mouse TIPR is also aligned. The box shows S57. The six residues derived from S57 are underlined. Asterisks show stop codons. Dots indicate differences in nucleotide bases and amino acid residues between mouse and human.
translated from an Ins(1,4,5)P $ R2 mRNA isoform that has the insertion of S57.
We next investigated whether the Ins(1,4,5)P $ R2 mRNA isoform that encoded TIPR was also expressed in the human. We designed the primers PH1 and PH2 to span the region from nt 439-827 of human Ins(1,4,5)P $ R2 cDNA (also numbered from the initiation codon). Two fragments were amplified from cDNA of human skeletal muscle and heart ; both sequences corresponded well to the expected region of human Ins(1,4,5)P $ R2 cDNA. Moreover, the larger fragment had the insertion of 57 bp at the same site as that of S57 in mouse Ins(1,4,5)P $ R2 cDNA. The inserted 57 bp in the human cDNA encodes six residues followed by four stop codons in the same frame as that of Ins(1,4,5)P $ R2 ( Figure 5 ). This result shows that the mRNA encoding TIPR is present also in human. Interestingly, mouse S57 has five stop codons and human S57 conserves the first four of them. This suggests that the expression of TIPR is necessary in skeletal muscle and heart. In contrast, the six residues derived from S57 were not conserved ; only two residues were identical between human and mouse. Therefore six residues might not have a role in the function of TIPR. We expressed the TIPR fused with HA in COS-7 cells ; anti-HA antibody stained the cytoplasmic region of the cells, suggesting that the expressed HA-TIPR was present in the cytoplasm (results not shown). TIPR is therefore expected to have the same function as that of the N-terminal 175 residues of Ins(1,4,5)P $ R2, which is in the cytoplasmic domain of the receptor.
One of the possible functions of TIPR is Ins(1,4,5)P $ binding because the N-terminal region of the type 1 Ins(1,4,5)P $ R is considered to be an Ins(1,4,5)P $ -binding domain [5, 6] . However, the experiment with the type 1 Ins(1,4,5)P $ R fragments expressed in E. coli showed that the region from residues 224-579 of this receptor is essential for the Ins(1,4,5)P $ binding [24] . Moreover, photolabelled Ins(1,4,5)P $ bound to the region from residues 406-501 of this receptor [25] . Because the N-terminal regions are quite well conserved between the type 1 and the type 2 receptors [26] , a similar region of Ins(1,4,5)P $ R2 is expected to be essential for the ligand binding. Therefore TIPR, which contains only the N-terminal 175 residues of Ins(1,4,5)P $ R2, does not seem to bind to Ins(1,4,5)P $ directly. Another possible function is the interaction with the C-terminal region of Ins(1,4,5)P $ R itself. Joseph et al. [10] digested the cerebellar Ins(1,4,5)P $ R with trypsin and showed that an Nterminal fragment associates with the C-terminal region. They suggest that the N-terminal Ins(1,4,5)P $ -binding domain is very close to the C-terminal channel domain and that this topology mediates the Ins(1,4,5)P $ -gated Ca# + channel activity of the receptor. If this hypothesis is applicable to Ins(1,4,5)P $ R2, TIPR might be able to interact with the C-terminal region of the receptor. Binding of TIPR to the C-terminal region of the type 2 receptor might affect the topology of the receptor and the Ca# + channel activity. We are now investigating whether or not TIPR has such functions.
It is interesting that the mRNA encoding TIPR was detected only in skeletal muscle and heart. The skeletal and cardiac muscles are special tissues where the ryanodine receptor is the main channel for Ca# + release from intracellular stores ; the released Ca# + triggers the contraction of these muscles [27] [28] [29] [30] . However, many studies suggest that Ins(1,4,5)P $ R has roles in these tissues. An Ins(1,4,5)P $ cascade is certainly present in skeletal muscle and heart. Some of the hormones that activate the Ins(1,4,5)P $ cascade enhance contraction of the heart [31, 32] . Ins(1,4,5)P $ R is actually expressed in cardiac myocyte and is localized at intercalated discs of the heart [33] [34] [35] . We detected the mRNA species for Ins(1,4,5)P $ R2 and the type 1 Ins(1,4,5)P $ R at similar levels in these muscle tissues (results not shown). The PCR analysis in the present study suggested that mRNA for TIPR was present a similar level to that for Ins(1,4,5)P $ R2 in heart. Therefore, although we were not able to detect TIPR or Ins(1,4,5)P $ R2 in skeletal muscle and heart by Western blot analysis (results not shown), TIPR is expected to be present and to have a role in these tissues. TIPR might regulate Ins(1,4,5)P $ Rmediated Ca# + release in both muscle types, where the ryanodine receptor-mediated Ca# + release mechanism has a main role in muscle contraction. Elucidation of the function of TIPR will give a new aspect to the mechanism of the Ins(1,4,5)P $ -induced Ca# + release system in these tissues.
